The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC 157 Legal? Understanding Its Status and Implications FDA Moves to Reevaluate Several Peptides American Med Spa Association Why would a patient trust a peptide more than a statin? STAT FDA's Overreach on Compounded Peptides BioCentury RFK Jr.'s peptide deregulation threatens the foundations of drug safety